Acetylcholinesterase antibodies and thyroid autoimmunity

Area of Science:

• Immunology
• Endocrinology
• Neuroscience

Background:

• Graves' ophthalmopathy pathogenesis is incompletely understood.
• A hypothesis suggests anti-thyroglobulin antibodies cross-react with acetylcholinesterase (AChE), contributing to Graves' ophthalmopathy.
• This study investigates the proposed link between anti-AChE antibodies and thyroid autoimmunity, specifically Graves' ophthalmopathy.

Purpose of the Study:

• To test the hypothesis that anti-thyroglobulin antibodies cross-react with AChE.
• To determine the prevalence of anti-AChE antibodies in patients with thyroid autoimmunity.
• To assess the association between anti-AChE antibodies and the severity of Graves' ophthalmopathy.

Main Methods:

• Enzyme-linked immunosorbent assay (ELISA) was used to detect anti-AChE antibodies.
• Patients with thyroid autoimmunity, normal subjects, and patients with non-organ specific autoimmunity were included.
• Inhibition studies and immunoblotting were performed to assess antibody cross-reactivity and binding sites.

Main Results:

• Anti-AChE antibodies were detected in 21% of patients with thyroid autoimmunity.
• Anti-AChE antibodies were also found in healthy controls and patients with other autoimmune conditions.
• No correlation was found between anti-AChE antibody levels and anti-thyroglobulin antibody levels or ophthalmopathy severity.
• Limited cross-reactivity between anti-thyroglobulin and anti-AChE antibodies was observed.

Conclusions:

• The presence of anti-AChE antibodies is frequent in sera but not specifically linked to thyroid autoimmunity.
• The hypothesis of significant cross-reactivity between anti-thyroglobulin and anti-AChE antibodies is not supported.
• Anti-AChE antibodies are unlikely to be the primary cause of Graves' ophthalmopathy.